These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

568 related articles for article (PubMed ID: 35445767)

  • 1. Prediction of spontaneous preterm birth and preterm prelabor rupture of membranes using maternal factors, obstetric history and biomarkers of placental function at 11-13 weeks.
    Chiu CPH; Feng Q; Chaemsaithong P; Sahota DS; Lau YY; Yeung YK; Yim LW; Chung JPW; Poon LC
    Ultrasound Obstet Gynecol; 2022 Aug; 60(2):192-199. PubMed ID: 35445767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for pre-eclampsia at 11-13 weeks' gestation: use of pregnancy-associated plasma protein-A, placental growth factor or both.
    Mazer Zumaeta A; Wright A; Syngelaki A; Maritsa VA; Da Silva AB; Nicolaides KH
    Ultrasound Obstet Gynecol; 2020 Sep; 56(3):400-407. PubMed ID: 32441401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic accuracy of first-trimester combined screening for early-onset and preterm pre-eclampsia at 8-10 compared with 11-13 weeks' gestation.
    Mendoza M; Garcia-Manau P; Arévalo S; Avilés M; Serrano B; Sánchez-Durán MÁ; Garcia-Ruiz I; Bonacina E; Carreras E
    Ultrasound Obstet Gynecol; 2021 Jan; 57(1):84-90. PubMed ID: 32388877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Routine first-trimester pre-eclampsia screening and risk of preterm birth.
    Giorgione V; Quintero Mendez O; Pinas A; Ansley W; Thilaganathan B
    Ultrasound Obstet Gynecol; 2022 Aug; 60(2):185-191. PubMed ID: 35441764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of pre-eclampsia in twin pregnancy by maternal factors and biomarkers at 11-13 weeks' gestation: data from EVENTS trial.
    Benkő Z; Wright A; Rehal A; Cimpoca B; Syngelaki A; Delgado JL; Tsokaki T; De Alvarado M; Vojtassakova D; Malligiannis Ntalianis K; Chaveeva P; Del Campo A; De Ganzo T; Resta C; Atanasova V; Accurti V; Villalain C; Aguilera J; Dojcinovska D; O'Gorman N; Plasencia W; Zingler E; Dutemeyer V; Alvar B; Casanova MC; Nicolaides KH
    Ultrasound Obstet Gynecol; 2021 Feb; 57(2):257-265. PubMed ID: 33142361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Routine first-trimester combined screening for pre-eclampsia: pregnancy-associated plasma protein-A or placental growth factor?
    Noël L; Guy GP; Jones S; Forenc K; Buck E; Papageorghiou AT; Thilaganathan B
    Ultrasound Obstet Gynecol; 2021 Oct; 58(4):540-545. PubMed ID: 33998078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for trisomy at 11-13 weeks' gestation: use of pregnancy-associated plasma protein-A, placental growth factor or both.
    Mazer Zumaeta A; Wright A; Syngelaki A; Maritsa VA; Bardani E; Nicolaides KH
    Ultrasound Obstet Gynecol; 2020 Sep; 56(3):408-415. PubMed ID: 32621353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of first-trimester combined screening for preterm pre-eclampsia: findings from cohort of 10 110 pregnancies in Spain.
    Cuenca-Gómez D; de Paco Matallana C; Rolle V; Valiño N; Revello R; Adiego B; Mendoza M; Molina FS; Carrillo MP; Delgado JL; Wright A; Santacruz B; Gil MM
    Ultrasound Obstet Gynecol; 2023 Oct; 62(4):522-530. PubMed ID: 37099759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of replacing or adding pregnancy-associated plasma protein-A at 11-13 weeks on screening for preterm pre-eclampsia.
    Wah YMI; Sahota DS; Chaemsaithong P; Wong L; Kwan AHW; Ting YH; Law KM; Leung TY; Poon LC
    Ultrasound Obstet Gynecol; 2022 Aug; 60(2):200-206. PubMed ID: 35468236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modified multiple marker aneuploidy screening as a primary screening test for preeclampsia.
    Huang T; Bedford HM; Rashid S; Rasasakaram E; Priston M; Mak-Tam E; Gibbons C; Meschino WS; Cuckle H; Mei-Dan E
    BMC Pregnancy Childbirth; 2022 Mar; 22(1):190. PubMed ID: 35260099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention.
    Poon LC; Shennan A; Hyett JA; Kapur A; Hadar E; Divakar H; McAuliffe F; da Silva Costa F; von Dadelszen P; McIntyre HD; Kihara AB; Di Renzo GC; Romero R; D'Alton M; Berghella V; Nicolaides KH; Hod M
    Int J Gynaecol Obstet; 2019 May; 145 Suppl 1(Suppl 1):1-33. PubMed ID: 31111484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of different methods of first-trimester screening for preterm pre-eclampsia: cohort study.
    Cuenca-Gómez D; De Paco Matallana C; Rolle V; Mendoza M; Valiño N; Revello R; Adiego B; Casanova MC; Molina FS; Delgado JL; Wright A; Figueras F; Nicolaides KH; Santacruz B; Gil MM
    Ultrasound Obstet Gynecol; 2024 Jul; 64(1):57-64. PubMed ID: 38411276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for pre-eclampsia by maternal serum glycosylated fibronectin at 11-13 weeks' gestation.
    Sokratous N; Bednorz M; Sarli P; Morillo Montes OE; Syngelaki A; Wright A; Nicolaides KH
    Ultrasound Obstet Gynecol; 2023 Oct; 62(4):504-511. PubMed ID: 37401855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ophthalmic artery Doppler in combination with other biomarkers in prediction of pre-eclampsia at 19-23 weeks' gestation.
    Sapantzoglou I; Wright A; Arozena MG; Campos RV; Charakida M; Nicolaides KH
    Ultrasound Obstet Gynecol; 2021 Jan; 57(1):75-83. PubMed ID: 33142353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation.
    Tan MY; Syngelaki A; Poon LC; Rolnik DL; O'Gorman N; Delgado JL; Akolekar R; Konstantinidou L; Tsavdaridou M; Galeva S; Ajdacka U; Molina FS; Persico N; Jani JC; Plasencia W; Greco E; Papaioannou G; Wright A; Wright D; Nicolaides KH
    Ultrasound Obstet Gynecol; 2018 Aug; 52(2):186-195. PubMed ID: 29896812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum PlGF compared with PAPP-A in first trimester screening for preterm pre-eclampsia: Adjusting for the effect of aspirin treatment.
    Wright D; Tan MY; O'Gorman N; Syngelaki A; Nicolaides KH
    BJOG; 2022 Jul; 129(8):1308-1317. PubMed ID: 35015330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The predictive value of maternal serum AFP to PAPP-A or b-hCG ratios in spontaneous preterm birth.
    Celik E; Melekoğlu R; Baygül A; Kalkan U; Şimşek Y
    J Obstet Gynaecol; 2022 Aug; 42(6):1956-1961. PubMed ID: 35620869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective evaluation of first-trimester screening strategy for preterm pre-eclampsia and its clinical applicability in China.
    Hu J; Gao J; Liu J; Meng H; Hao N; Song Y; Ma L; Luo W; Sun J; Gao W; Meng W; Sun Y
    Ultrasound Obstet Gynecol; 2021 Oct; 58(4):529-539. PubMed ID: 33817865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of machine-learning model for first-trimester prediction of pre-eclampsia using cohort from PREVAL study.
    Gil MM; Cuenca-Gómez D; Rolle V; Pertegal M; Díaz C; Revello R; Adiego B; Mendoza M; Molina FS; Santacruz B; Ansbacher-Feldman Z; Meiri H; Martin-Alonso R; Louzoun Y; De Paco Matallana C
    Ultrasound Obstet Gynecol; 2024 Jan; 63(1):68-74. PubMed ID: 37698356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective evaluation of screening performance of first-trimester prediction models for preterm preeclampsia in an Asian population.
    Chaemsaithong P; Pooh RK; Zheng M; Ma R; Chaiyasit N; Tokunaka M; Shaw SW; Seshadri S; Choolani M; Wataganara T; Yeo GSH; Wright A; Leung WC; Sekizawa A; Hu Y; Naruse K; Saito S; Sahota D; Leung TY; Poon LC
    Am J Obstet Gynecol; 2019 Dec; 221(6):650.e1-650.e16. PubMed ID: 31589866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.